Compare · ALGN vs FEED
ALGN vs FEED
Side-by-side comparison of Align Technology Inc. (ALGN) and ENvue Medical Inc. (FEED): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both ALGN and FEED operate in Industrial Specialties (Health Care), so they compete in similar markets.
- ALGN is the larger of the two at $12.32B, about 2560.0x FEED ($4.8M).
- Over the past year, ALGN is down 4.9% and FEED is down 91.3% - ALGN leads by 86.4 points.
- ALGN has been more active in the news (16 items in the past 4 weeks vs 7 for FEED).
- ALGN has more recent analyst coverage (25 ratings vs 0 for FEED).
- Company
- Align Technology Inc.
- ENvue Medical Inc.
- Price
- $172.13+2.64%
- $0.78-10.67%
- Market cap
- $12.32B
- $4.8M
- 1M return
- +2.28%
- -41.21%
- 1Y return
- -4.89%
- -91.25%
- Industry
- Industrial Specialties
- Industrial Specialties
- Exchange
- NASDAQ
- NASDAQ
- IPO
- 2001
- News (4w)
- 16
- 7
- Recent ratings
- 25
- 0
Align Technology Inc.
Align Technology, Inc., a medical device company, designs, manufactures, and markets Invisalign clear aligners and iTero intraoral scanners and services for orthodontists and general practitioner dentists, and restorative and aesthetic dentistry. It operates in two segments, Clear Aligner; and Scanners and Services. The Clear Aligner segment consists of comprehensive products, including Invisalign comprehensive treatment that addresses the orthodontic needs of teenage patients, such as mandibular advancement, compliance indicators, and compensation for tooth eruption; and Invisalign First Phase I and Invisalign First Comprehensive Phase 2 package for younger patients generally between the ages of seven and ten years, which is a mixture of primary/baby and permanent teeth. This segment's non-comprehensive products comprise Invisalign moderate, lite and express packages, and Invisalign go; and non-case products include retention products, Invisalign training fees, and sales of ancillary products, such as cleaning material, and adjusting tools used by dental professionals during the course of treatment. The Scanners and Services segment offers iTero scanner, a single hardware platform with software options for restorative or orthodontic procedures; restorative software for general practitioner dentists, prosthodontists, periodontists, and oral surgeons; and software for orthodontists for digital records storage, orthodontic diagnosis, and for the fabrication of printed models and retainers. This segment also provides computer-aided design and computer-aided manufacturing services; ancillary products, such as disposable sleeves for the wand; iTero model and dies; third party scanners and digital scans; Invisalign outcome simulator, a chair-side and cloud-based application for the iTero scanner; Invisalign progress assessment tool; and TimeLapse technology, which allows doctors or practitioners to compare a patient's historic 3D scans to the present-day scan. The company sells its products in the United States, Switzerland, China, and internationally. Align Technology, Inc. was incorporated in 1997 and is headquartered in Tempe, Arizona.
Latest ALGN
- Align Technology Awards Funding to Universities Worldwide for Advancing Orthodontic and Dental Research
- SEC Form SD filed by Align Technology Inc.
- Director Vitalone Britt J. converted options into 1,443 shares (SEC Form 4)
- Director Siegel Susan E converted options into 1,745 shares, increasing direct ownership by 19% to 10,723 units (SEC Form 4)
- Director Saia Andrea Lynn converted options into 1,745 shares, increasing direct ownership by 11% to 17,318 units (SEC Form 4)
- Director Poul Mojdeh converted options into 1,745 shares, increasing direct ownership by 97% to 3,553 units (SEC Form 4)
- Director Myong Anne converted options into 1,745 shares, increasing direct ownership by 22% to 9,830 units (SEC Form 4)
- Director Larkin C Raymond Jr converted options into 2,326 shares, increasing direct ownership by 9% to 27,454 units (SEC Form 4)
- Director Dallas Kevin J converted options into 1,745 shares, increasing direct ownership by 12% to 16,168 units (SEC Form 4)
- Director Lacob Joseph converted options into 1,745 shares (SEC Form 4)
Latest FEED
- ENvue Medical Expands into Burn Intensive Care Unit at Major Academic Health Network
- ENvue Medical Announces Publication of Landmark Independent Study Highlighting Significant Safety, Time-, and Cost-Saving Benefits of ENvue Navigation Platform in Multi-Hospital System
- SEC Form EFFECT filed by ENvue Medical Inc.
- SEC Form 424B3 filed by ENvue Medical Inc.
- ENvue Medical to Showcase ENvue™ Navigation Platform at AACN NTI 2026
- SEC Form S-3 filed by ENvue Medical Inc.
- SEC Form 10-Q filed by ENvue Medical Inc.
- SEC Form NT 10-Q filed by ENvue Medical Inc.
- SEC Form 144 filed by ENvue Medical Inc.
- ENvue Medical Secures Three-Year Contract Renewal at 12-Hospital U.S. Health Network as the ENvue™ Navigation Platform Becomes Standard of Care